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P U B L I S H E D B Y E L S E V I E R I N C .LettersPrognostic Value of
ST-Segment Elevation
in Lead aVR in Patients
With Type A Acute
Aortic DissectionIn type A acute aortic dissection (AAD), ST-T changes
on the admission electrocardiogram (ECG) are asso-
ciated with poor outcomes (1,2). Although ST-
segment elevation in lead aVR (STE-aVR) is an ECG
marker of severe acute myocardial ischemia (3), its
prognostic signiﬁcance in type A AAD remains un-
known. We studied the relationship of admission ECG
ﬁndings to clinical features at admission and in-
hospital death in 409 patients (mean age, 64  12
years; 231 men; mean time from symptom onset to
admission, 3.1  2.4 h; the rate of urgent surgery,
90%) with type A AAD who were admitted within 12 h
from symptom onset. The Ethics Committee at our
institution approved the study, and all subjects gave
informed consent.
Twelve-lead ECGs were recorded on admission.
Left ventricular hypertrophy was deﬁned using the
Sokolow-Lyon voltage criteria. We used globally
accepted criteria deﬁning ST-T changes (4) to di-
agnose acute myocardial ischemia. Patients were
divided into the 4 groups: no signiﬁcant ST-T changes
(n ¼ 110, group A), bundle branch block or left ven-
tricular hypertrophy (n ¼ 86, group B), and the
absence (n ¼ 163, group C) or the presence (n ¼ 50,
group D) of STE-aVR $0.05 mV with ST-T changes in
other leads. Renal dysfunction was deﬁned as an
estimated glomerular ﬁltration rate calculated using
serum creatinine levels on admission of <60 ml/
min/1.73 m2.
Data were compared by 1-way analysis of variance
or chi-square analysis. Multivariate logistic regres-
sion analysis was used to identify clinical predictors
at admission of in-hospital mortality among the 4
ECG patterns and variables associated (p < 0.05) with
this outcome on univariate analysis.
In groups A, B, C, and D, the rates of shock were
2.7%, 12.8%, 19.0%, and 64.0%; the rates of cardiac
tamponade were 3.6%, 20.9%, 17.8%, and 60.0%;and the rates of renal dysfunction were 40.9%, 55.8%,
56.4%, and 68.0% (all p < 0.01), respectively. Among
370 patients who underwent urgent surgery in groups
A, B, C, and D, the rates of coronary ostial involve-
ment were 3.0%, 2.6%, 9.9%, and 31.8% (p < 0.01);
the rates of left coronary artery involvement were
2.0%, 1.3%, 0.7%, and 18.2% (p < 0.01); the rates of
right coronary artery involvement were 1.0%, 1.3%,
7.9%, and 9.1% (p ¼ 0.02); and the rates of both left
and right coronary artery involvement were 0%, 0%,
1.3%, and 4.5% (p ¼ 0.07), respectively. Age, sex,
time from symptom onset to admission, and the rate
of urgent surgery were similar among the 4 groups.
STE-aVR was associated with the highest in-
hospital mortality, regardless of treatment strategy
(Figure 1). Age, shock, cardiac tamponade, and renal
dysfunction were included as variables in the multi-
variate analysis, but were not signiﬁcantly related to
in-hospital death. STE-aVR was the strongest predic-
tor of in-hospital death (odds ratio: 23.4; 95% conﬁ-
dence interval: 6.10 to 62.2; p < 0.01), followed by no
surgical treatment (odds ratio: 10.4; 95% conﬁdence
interval: 3.71 to 29.2; p < 0.01).
This study demonstrated that in patients with type
A AAD, STE-aVR at presentation was associated with
serious conditions such as shock, cardiac tamponade,
or coronary ostial involvement and was the strongest
predictor of in-hospital death.
In acute coronary syndrome (ACS), STE-aVR re-
ﬂects severe acute myocardial ischemia due to severe
coronary artery disease (3). In ST-segment elevation
myocardial infarction, STE-aVR is caused by trans-
mural ischemia in the basal septum, often resulting
from obstruction of the left main or the proximal
left anterior descending coronary artery. In non–
ST-segment elevation ACS, lead aVR is referred to as
a cavity lead, and STE-aVR might reﬂect global sub-
endocardial ischemia of the left ventricle, often
associated with left main or 3-vessel disease.
In type A AAD, the mechanisms underlying STE-
aVR remain unclear. Under certain limited condi-
tions, however, severe acute myocardial ischemia is
thought to provoke STE-aVR. If the left coronary ar-
tery ostium is completely obstructed, transmural
ischemia in the basal septum can cause STE-aVR. In
coronary ostial involvement (especially of the left
coronary artery) associated with severe stenosis but
FIGURE 1 In-Hospital Mortality Stratiﬁed According to Electrocardiographic Patterns
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2571not complete occlusion, global subendocardial is-
chemia of the left ventricle can also cause STE-aVR.
Furthermore, serious conditions, such as shock and
cardiac tamponade, can lead to severe suben-
docardial ischemia of the left ventricle (2), resulting
in STE-aVR. In any of these conditions, patients
with STE-aVR are considered to have a poor prog-
nosis. To our knowledge, this is the ﬁrst study to
demonstrate the prognostic signiﬁcance of STE-aVR
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Particle Number Is
Associated With
Cardiovascular Events
Among Those Not
Classiﬁed Into Statin
Beneﬁt GroupsThe 2013 American Heart Association/American Col-
lege of Cardiology guideline for the treatment of
cholesterol to reduce the risk of cardiovascular dis-
ease (CVD) deﬁned 4 groups of patients who are
candidates for statin treatment (1). For those not
